KHC
PFE icon

Koesten Hirschmann & Crabtree’s Pfizer PFE Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,473
Closed -$37.5K – 176
2025
Q3 		$37.5K Buy
1,473
+25
+2% +$617 0.02% 94
2025
Q2 		$35.1K Buy
1,448
+25
+2% +$583 0.02% 95
2025
Q1 		$36.1K Buy
1,423
+23
+2% +$602 0.02% 98
2024
Q4 		$37.2K Buy
1,400
+22
+2% +$597 0.02% 93
2024
Q3 		$39.9K Buy
1,378
+12
+0.9% +$350 0.02% 90
2024
Q2 		$37.9K Hold
1,366
– – 0.02% 99
2024
Q1 		$37.9K Buy
1,366
+50
+4% +$1.39K 0.02% 99
2023
Q4 		$37.9K Buy
1,316
+18
+1% +$544 0.03% 82
2023
Q3 		$43.1K Buy
1,298
+15
+1% +$530 0.03% 57
2023
Q2 		$47.1K Buy
1,283
+13
+1% +$506 0.04% 60
2023
Q1 		$51.8K Buy
1,270
+13
+1% +$561 0.04% 61
2022
Q4 		$64.4K Buy
+1,257
New +$60.3K 0.05% 55

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Koesten Hirschmann & Crabtree's PFE Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Pfizer (PFE) in Q4 2025, closing a stake of 1,473 shares — an estimated $37.5K sold.

Koesten Hirschmann & Crabtree first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $64.4K in Q4 2022. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 1,473 Pfizer shares in Q4 2025, an estimated $37.5K.
  • Koesten Hirschmann & Crabtree first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
  • Koesten Hirschmann & Crabtree's Pfizer position peaked at $64.4K in Q4 2022.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.